Research Seminar

Pharmacology of asthma and COPD: current and future developments

Napoli, Italy

10-11 June, 2021

Information: ERS Statement on COVID-19 and upcoming ERS events

Objectives

This research seminar will allow participants to:

  • Understand the nature and mechanisms of actions of the current pharmacological therapy of obstructive lung disease
  • Analyse the key challenges faced during clinical development of anti-inflammatory drugs for asthma and COPD
  • Explain concepts related to lung remodelling and regeneration in airway disease
  • Evaluate challenges in the treatment of patients with asthma and COPD
  • Synthetize mechanisms of steroid resistance, drug interactions and pharmacogenetics in obstructive lung disease
  • Predict ways to optimize drug therapy in asthma and COPD
  • Network and have the possibility to engage in high-level debates and refine their ideas

Registration

Admittance to this seminar is upon selection due to the limited number of places available. Registration is now open. If you want to attend, please complete the online registration form by the registration deadline: Monday 1 March 2021. Notification of registrant selections will be sent by end of April 2021.

Any questions? Please contact scientific@ersnet.org